Updated clinical guidelines on Effient treatment for ACS patients
Effient® (prasugrel) tablets, a new antiplatelet medicine, was added as a treatment option in two clinical guideline updates: one for patients receiving percutaneous coronary intervention (...
News-Medical-Net,
Thu Nov 19 03:57:48 PST 2009
• Found on Yahoo! News
New pre-clinical data from Alnylam Pharmaceuticals' ALN-VSP program presented
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced new pre-clinical data from its ALN-VSP program presented at the AACR-NCI-EORTC Molecular Targets and Canc...
News-Medical-Net,
Wed Nov 18 04:43:18 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News